{"id":14702,"date":"2014-11-12T00:00:53","date_gmt":"2014-11-11T23:00:53","guid":{"rendered":"http:\/\/alcyon:7777\/transgene170914\/?p=14702"},"modified":"2025-11-12T16:39:53","modified_gmt":"2025-11-12T15:39:53","slug":"tg4010-immunotherapy-combined-with-first-line-therapy-in-advanced-non-small-cell-lung-cancer-nsclc-phase-2b-results-of-the-time-study-2","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/tg4010-immunotherapy-combined-with-first-line-therapy-in-advanced-non-small-cell-lung-cancer-nsclc-phase-2b-results-of-the-time-study-2\/","title":{"rendered":"TG4010 Immunotherapy Combined with First-line Therapy in Advanced Non- Small Cell Lung Cancer (NSCLC). Phase 2b Results of the TIME Study"},"content":{"rendered":"<p><a href=\"http:\/\/www.immunotherapyofcancer.org\/content\/2\/S3\/O12\"><\/a><br \/>\nElisabeth Quoix, et al.<br \/>\nJournal for Immunotherapy of Cancer, 2014, 2 (suppl. 3), O12 \u2013 <a href=\"http:\/\/www.immunotherapyofcancer.org\/content\/2\/S3\/O12\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Download the article<\/strong><\/a><br \/>\n<em>Publication<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Elisabeth Quoix, et al. Journal for Immunotherapy of Cancer, 2014, 2 (suppl. 3), O12 \u2013 Download the article Publication<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[181,146,5,16],"tags":[],"class_list":["post-14702","post","type-post","status-publish","format-standard","hentry","category-other-fr","category-146","category-publication-fr","category-tg4010-fr","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"alcyon","author_link":"https:\/\/www.transgene.com\/fr\/author\/alcyon\/"},"uagb_comment_info":0,"uagb_excerpt":"Elisabeth Quoix, et al. Journal for Immunotherapy of Cancer, 2014, 2 (suppl. 3), O12 \u2013 Download the article Publication","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/14702","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=14702"}],"version-history":[{"count":1,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/14702\/revisions"}],"predecessor-version":[{"id":38818,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/14702\/revisions\/38818"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=14702"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=14702"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=14702"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}